Meiho University Institutional Repository:Item 987654321/1716
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 2876/3793 (76%)
造訪人次 : 3863016      線上人數 : 291
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於MUIR ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.meiho.edu.tw/ir/handle/987654321/1716


    題名: Enhanced protection against pulmonary hypertension with sildenafil and endothelial progenitor cell in rats.
    作者: Sun CK;Lin YC;Yuen CM;Chua S;Chang LT;Sheu JJ;Lee FY;Fu M;Leu S;Yip HK
    日期: 2011-05
    上傳時間: 2012-09-05T07:42:15Z (UTC)
    摘要: BACKGROUND: Sildenafil and bone marrow-derived endothelial progenitor cells (BMDEPCs) have been shown to ameliorate monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) in the rat. We test whether combined sildenafil and BMDEPC treatment exerts additional protection against MCT-induced PAH in rats.

    METHODS: Male Sprague-Dawley rats were randomized to receive saline injection only (group 1), MCT (70mg/kg) only (group 2), MCT plus autologous BMDEPC (2.0×10(6)cells) transplantation (group 3), MCT with sildenafil (30mg/kg/day) (group 4), and MCT with combined BMDEPCs-sildenafil (30mg/kg/day) (group 5). Intravenous BMDEPC and oral sildenafil were given on day 3 after MCT administration. Hemodynamics were analyzed using Labchart software, whereas cellular and molecular parameters were measured using flow cytometry, real-time PCR, TUNEL assay, Western blot, and immunohistochemical staining.

    RESULTS: By day 35 following MCT treatment, lower expression of connexin43, protein kinase C-ε, Bcl-2, and endothelial nitric oxide synthase and higher expression of tumor necrosis factor-α and caspase 3 were found in right ventricle (RV) and lung in group 2 compared with other groups (all p<0.05). The number of alveolar sacs and lung arterioles were also lower in group 2 than in other groups (all p<0.05). Furthermore, RV systolic pressure (RVSP), RV weight, and RV-to-final body weight ratio were substantially increased in group 2 than in other groups, and notably higher in groups 3 and 4 than in groups 1 and 5 (all p<0.0001).

    CONCLUSIONS: Combined therapy with autologous BMDEPC and sildenafil is superior to either BMDPEC or sildenafil alone for preventing MCT-induced PAH.
    關聯: Int J Cardiol. 2011 May 25. [Epub ahead of print]
    顯示於類別:[護理系] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.htmlEnhanced protection against pulmonary hypertension with sildenafil and endothelial progenitor cell in rats.0KbHTML1086檢視/開啟


    檢視Licence

    在MUIR中所有的資料項目都受到原著作權保護.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋